Nateglip 60 Tablet contains Nateglinide 60 mg, an oral antidiabetic medicine that helps manage type 2 diabetes mellitus by stimulating the pancreas to release insulin. It acts rapidly and is particularly effective in controlling post-meal blood glucose levels, reducing the risk of diabetic complications.
Belonging to the diabetes care segment, Nateglip 60 Tablet is a reliable choice for patients needing short-acting insulin secretagogues. It complements diet and exercise plans and can be used alone or with other oral hypoglycemics as part of combination therapy.
Nateglip 60 Tablet is widely prescribed in endocrinology and general practice, ensuring consistent market demand. It is an essential product in hospital, clinic, and pharmacy setups due to its effectiveness and safety profile.
For PCD pharma franchise partners, exporters, and third-party manufacturers, Nateglip 60 Tablet offers a steady business opportunity with strong prescription support and repeat orders. Its growing demand in the antidiabetic segment makes it a high-margin addition to any B2B pharma portfolio.